Friday, June 1, 2012

Using chitosan core-shell nanoparticle for breast cancer treatment

Home > Press > Using chitosan core-shell nanoparticle for breast cancer treatment

Abstract:
Researchers at National Nanotechnology Center (NANOTEC) and King Mongkut's University of Technology Thonburi (KMUTT) have successfully developed a target drug delivery system using folate-conjugated pluronic F127/chitosan core-shell nanoparticles to deliver doxorubicin (DOX) to target cancer cells focusing on breast cancer.

Pathumthani, Thailand | Posted on May 31st, 2012

"DOX is one of the most commonly used chemotherapeutic agents for cancer treatment including breast cancer. However, DOX is also considered a poor soluble drug that is toxic to healthy tissues" said Dr. Nuttaporn Pimpha, a NANOTEC researcher at Hybrid Nanostructure and Nanocomposite. "By using core-shell nanoparticles from folate-conjugated pluronic F127/chitosan we were able to develop a delivery vector that has greater targeting ability, chemical stability and lower cytotoxicity".

As in many developing countries, cancer in Thailand is becoming a significant health problem. Cervix and breast cancer is the leading cause of death in Thai women. The only commercial DOX - encapsulated liposome available is Doxil. However, Doxil has a short half-life in microcirculation and is unstable in the blood stream. Hence there is a need to find a more controlled and stable DOX carrier system.

The researchers reported their work in a paper published by the Journal of Nanomaterials.

####

For more information, please click here

Contacts:
Ramjitti Indaraprasirt
Manager
Public Relations Section
NANOTEC
02-564-7100 ext: 6617

Copyright ? NANOTEC

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

News and information

Nanostart-holding MagForce signs distribution agreement with Turkish medical product distribution company Tek Grup May 31st, 2012

Asylum Research Introduces the AFM Industry?s First Five-Year Instrument Warranty May 31st, 2012

Mirrorcle Technologies? MEMS mirrors scan full hemisphere May 31st, 2012

ISGS Summer School 2012 ? 22-26 July 2012 ? Paris, France May 31st, 2012

Nanomedicine

Nanostart-holding MagForce signs distribution agreement with Turkish medical product distribution company Tek Grup May 31st, 2012

RediHeal Family of Products now Available at MWI May 30th, 2012

Harris & Harris Group Notes OpGen and Life Technologies Collaboration Agreement May 30th, 2012

8th NanoBio-Europe conference, Varese, 18 - 20 June 2012 May 30th, 2012

Announcements

JEOL Introduces Ultra-high Resolution Analytical Field Emission SEM: Highest performance FE-SEM optimized for sub-nm resolution imaging of any type of sample May 31st, 2012

SEFCU, CNSE and Girls Inc. Announce Launch of Nation's First Nanotechnology-based Eureka!? Program: The $800,000 pioneering initiative will inspire young women to pursue high-tech education and careers, further supporting the growth of New York?s emerging nanotechnology sector May 31st, 2012

Leading Physicist becomes New Executive Director of the National Institute for Nanotechnology May 31st, 2012

Mirrorcle Technologies? MEMS mirrors scan full hemisphere May 31st, 2012

lsu football bcs jay z glory alabama crimson tide barry larkin jay z new song torrie wilson

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.